R. M. Kannan, PhD

Professor

Department of Chem. Eng. & Mat. Sci.
Department of Biomedical Engineering
Director, NICHD Perinatology Research Branch-Nanotechnology Lab
Member of Karmanos Cancer Institute

Phone : (313)-577-3879
Email: rkannan.wsu@gmail.com

Curriculum Vitae: pdf

Education:

B.E. (Hons.): Birla Institute of Technology and Science, 1987
Ph.D.: California Institute of Technology, 1994
Postdoctoral Associate: University of Minnesota, 1994-1995

Awards and Honors:

Director, Nanotechnology Lab, NICHD Perinatology Research Branch, 2008-
NIH Study section membership (NCI Special Emphasis Panels, IMST W53 SBIR)
Editorial Board, NanoMedicine: Nanotechnology, Biology and Medicine
Ralph C. Wilson Foundation Scholar (2007)
Fellow, The American Academy of Nanomedicine, 2006-
NSF CAREER Award (1999)
3M Non-tenured Faculty Award (1998 – 2000, 2001-2002)
Wayne State University Faculty Research Award (1997-1998, 1998-1999)
Unilever Award for outstanding Ph.D. thesis in polymer Science by ACS (1995)
American Chemical Society Honor symposium for Unilever award (1995)
Charles Lee Powell Foundation Graduate Fellowship at Caltech (1992-1994)
Du Pont Graduate Fellowship at Caltech (1989 – 1990)

Research Interests:

Development of dendrimer/hyperbranched polymer based targeted drug delivery systems (Applications to Asthma, Cancer and Thrombolysis drugs): Synthesis, in-vitro, in-vivo characterization, microscopy
click here for more info

Development of method to produce highly dispersed, highly reinforced polymer clay nanocomposites utilizing a patented supercritical carbon dioxide process
click here for more info

Instruments in lab:

Rheo-optical FTIR spectroscope

Flow birefringence RSAII rheometer

Fluorescence microscopy

High Performance Liquid Chromatography

Differential Scanning Calorimeter

Funding:

NSF-CAREER DMR 9876221

Children's Research Center of Michigan - Children's Hospital of Michigan

NASA, National Institute of Health - PPRU

3M, GE, WSU Institute of Manufacturing Research

Click here for a full list of publications

Selected Publications
 

1. ‘Intrinsic targeting of neuroinflammation by polyamidoamine dendrimers in a rabbit model of cerebral palsy’ H.Dai, R.Navath, B.Balakrishnan, B.Raja Guru, M.Mishra, R.Romero, R.M.Kannan*, S.Kannan*, in press, Future Medicine:Nanomedicine, June. (2010) (journal impact factor:6.05).
    
2. ‘Amino acid functionalized dendrimers with hetero-bifunctional chemoselective peripheral groups for drug delivery’, R.Navath, A.Menjoge, B.Wang, R.Romero, S.Kannan, R.M.Kannan*, DOI: 10.1021/bm100186b, Biomacromolecules, May (2010) (journal impact factor:4.2) .
    
3. ‘Transport and Biodistribution of Dendrimers Across Human Fetal Membranes: Implications for Intravaginal Administration of Dendrimers’, A. R. Menjoge, R. S. Navath, A. Asad, S. Kannan, C. J. Kim, R.Romero, R. M. Kannan*, Biomaterials, 31(8), 5007-5021 (2010) (journal impact factor:6.6).
    
4. ‘Dendrimer-Based Drug and Imaging Conjugates: Design Considerations for Nanomedical Applications’, A.Menjoge, R.M.Kannan*, D.Tomalia*, Invited Foundation review, Drug Discovery Today, 15(5),171-185 (2010) (journal impact factor: 7.1).
    
5. ’Multifunctional Dendrimer-templated Antibody Presentation on Biosensor Surfaces for Improved Biomarker Detection’, H.Han, R.M.Kannan*, S.Wang, G.Z.Mao, J.P.Kusanovic, R.Romero, Advanced Functional Materials , 19, 1–13 (2009) (journal impact factor: 7.5).
    
6. ‘Drug release mechanisms and kinetics from dendrimer-drug conjugates with glutathione sensitive linkers’, Emre, YK, R. Navath, B. Wang, R. Romero, S. Kannan, RM Kannan*, Biomaterials, 30, 2112-2121 (2009) (journal impact factor:6.6).
    
7. ‘Supercritical CO2-processed dispersed polystyrene-clay nanocomposites’, ‘M. Manitiu, R. Bellair, S. Horsch, E. Gulari and R. M. Kannan*, Macromolecules, 41,8038-8046, 2008 (journal impact factor:4.4).
    
8. ‘Dendrimer Effect of surface functionality on the cellular trafficking of dendrimers’, O. Pillai, R. Inapagolla, RM.Kannan, S.Kannan*, Biomaterials (2008), 29(24-25), 3469-3476 (2008) (journal impact factor: 6.6).
    
9. ‘Activity of dendrimer-methotrexate conjugates in sensitive and resistant cell lines’, S. Gurdag, J. Khandare, S. Staples, R. M. Kannan*, L. Matherly, Bioconjugate Chem. (2006), 17(2):275-83 (among the top 10 most accessed articles during that period, Faculty of 1000 publication, highlighted by NIH (Nano) and other publications) (journal impact factor: 4.4).